45 results on '"Matano, Tetsuro"'
Search Results
2. Sustained gut dysbiosis and intestinal inflammation show correlation with weight gain in person with chronic HIV infection on antiretroviral therapy.
- Author
-
Ishizaka, Aya, Koga, Michiko, Mizutani, Taketoshi, Suzuki, Yutaka, Matano, Tetsuro, and Yotsuyanagi, Hiroshi
- Subjects
HIV infections ,WEIGHT gain ,ANTIRETROVIRAL agents ,BACTERIAL metabolism ,MONOCYTE chemotactic factor ,DYSBIOSIS ,SHORT-chain fatty acids - Abstract
Background: Person with human immunodeficiency virus type-1 (PWH) are prone to chronic inflammation due to residual viral production, even with antiretroviral therapy (ART), which increases the risk of age-related diseases. There is also limited information on changes in the intestinal environment of PWH during ART. In this longitudinal study, we investigated changes in the gut microbiota, persistence of chronic inflammation, interactions between the gut environment and inflammation, and metabolic changes in PWH using long-term ART. Results: We analyzed changes in clinical parameters and gut microbiota in 46 PWH over a mean period of 4 years to understand the influence of gut dysbiosis on inflammation. Overall, changes in the gut microbiota included a decrease in some bacteria, mainly involved in short-chain fatty acid (SCFA) production, and an increase in certain opportunistic bacteria. Throughout the study period, an increase in bacterial-specific metabolic activity was observed in the intestinal environment. Continued decline in certain bacteria belonging to the Clostridia class and metabolic changes in gut bacteria involved in glucose metabolism. Additionally, patients with a low abundance of Parabacteroides exhibited low bacterial alpha diversity and a significant increase in body mass index (BMI) during the study period. Monocyte chemoattractant protein 1, a marker of macrophage activation in the plasma, continued to increase from baseline (first stool collection timepoint) to follow-up (second stool collection timepoint), demonstrating a mild correlation with BMI. Elevated BMI was mild to moderately correlated with elevated levels of plasma interleukin 16 and chemokine ligand 13, both of which may play a role in intestinal inflammation and bacterial translocation within the gut microbiota. The rate of BMI increase correlated with the rate of decrease in certain SCFA-producing bacteria, such as Anaerostipes and Coprococcus 3. Conclusion: Our data suggest that despite effective ART, PWH with chronic inflammation exhibit persistent dysbiosis associated with gut inflammation, resulting in a transition to an intestinal environment with metabolic consequences. Moreover, the loss of certain bacteria such as Parabacteroides in PWH correlates with weight gain and may contribute to the development of metabolic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Community based multi-disease health screening as an opportunity for early detection of HIV cases and linking them to care.
- Author
-
Abana, Christopher Z-Y., Kushitor, Dennis K., Asigbee, Theodore W., Parbie, Prince K., Ishikawa, Koichi, Kiyono, Hiroshi, Mizutani, Taketoshi, Siaw, Samuel, Ofori, Sampson B., Addo-Tetebo, Gifty, Ansong, Maclean R. D., Williams, Marion, Morton, Samuel, Danquah, George, Matano, Tetsuro, Ampofo, William K., and Bonney, Evelyn Y.
- Subjects
SYPHILIS ,MEDICAL screening ,COMMUNITIES ,HEPATITIS B ,HIV ,HEPATITIS B virus - Abstract
Background: The 95-95-95 UNAIDS global strategy was adapted to end the AIDS epidemic by 2030. The target is based on the premise that early detection of HIV-infected persons and linking them to treatment regardless of their CD4 counts will lead to sustained viral suppression. HIV testing strategies to increase uptake of testing in Western and Central Africa remain inadequate. Hence, a high proportion of people living with HIV in this region do not know their status. This report describes the implementation of a community based multi-disease health screening (also known as "Know Your Status" -KYS), as part of basic science research, in a way that contributed to achieving public health goals. Methods: A community based multi-disease health screening was conducted in 7 communities within the Eastern region of Ghana between November 2017 and April 2018, to recruit and match HIV seronegative persons to HIV seropositive persons in a case-control HIV gut microbiota study. Health assessments included blood pressure, body mass index, blood sugar, Hepatitis B virus, syphilis, and HIV testing for those who consented. HIV seronegative participants who consented were consecutively enrolled in an ongoing HIV gut microbiota case-control study. Descriptive statistics (percentages) were used to analyze data. Results: Out of 738 people screened during the exercise, 700 consented to HIV testing and 23 (3%) were HIV positive. Hepatitis B virus infection was detected in 4% (33/738) and Syphilis in 2% (17/738). Co-infection of HIV and HBV was detected in 4 persons. The HIV prevalence of 3% found in these communities is higher than both the national prevalence of 1.7% and the Eastern Regional prevalence of 2.7 in 2018. Conclusion: Community based multi-disease health screening, such as the one undertaken in our study could be critical for identifying HIV infected persons from the community and linking them to care. In the case of HIV, it will greatly contribute to achieving the first two 95s and working towards ending AIDS by 2030. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection.
- Author
-
Hau, Trang Thi Thu, Nishizawa, Masako, Harada, Shigeyoshi, Phan, My Ha, Kanno, Yoshiaki, Nomura, Takushi, Matsuoka, Saori, Kawana-Tachikawa, Ai, Hall, William W., Matano, Tetsuro, Nguyen, Lan Anh Thi, and Yamamoto, Hiroyuki
- Published
- 2022
- Full Text
- View/download PDF
5. Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2.
- Author
-
Saso, Wakana, Yamasaki, Masako, Nakakita, Shin-ichi, Fukushi, Shuetsu, Tsuchimoto, Kana, Watanabe, Noriyuki, Sriwilaijaroen, Nongluk, Kanie, Osamu, Muramatsu, Masamichi, Takahashi, Yoshimasa, Matano, Tetsuro, Takeda, Makoto, Suzuki, Yasuo, and Watashi, Koichi
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been transmitted across all over the world, in contrast to the limited epidemic of genetically- and virologically-related SARS-CoV. However, the molecular basis explaining the difference in the virological characteristics among SARS-CoV-2 and SARS-CoV has been poorly defined. Here we identified that host sialoglycans play a significant role in the efficient spread of SARS-CoV-2 infection, while this was not the case with SARS-CoV. SARS-CoV-2 infection was significantly inhibited by α2-6-linked sialic acid-containing compounds, but not by α2–3 analog, in VeroE6/TMPRSS2 cells. The α2-6-linked compound bound to SARS-CoV-2 spike S1 subunit to competitively inhibit SARS-CoV-2 attachment to cells. Enzymatic removal of cell surface sialic acids impaired the interaction between SARS-CoV-2 spike and angiotensin-converting enzyme 2 (ACE2), and suppressed the efficient spread of SARS-CoV-2 infection over time, in contrast to its least effect on SARS-CoV spread. Our study provides a novel molecular basis of SARS-CoV-2 infection which illustrates the distinctive characteristics from SARS-CoV. Author summary: SARS-CoV-2, which has been highly transmissible and rapidly spreading worldwide, has caused approximately 458 million confirmed cases of COVID-19 with more than 6 million deaths by March 2022. Here we found that SARS-CoV-2 infection was significantly inhibited by α2-6-linked sialic acid-containing compounds and by depletion of cell surface sialic acid with only a minor effect on SARS-CoV infection. We identified that SARS-CoV-2 spike S1 subunit directly binds to α2-6-linked sialoglycans for efficient attachment to host cell surface. Our finding indicated that host sialoglycans play a significant role in the efficient infection of SARS-CoV-2, which provides a novel understanding of the molecular basis explaining the rapid spread of SARS-CoV-2 over SARS-CoV. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Super high-resolution single-molecule sequence-based typing of HLA class I alleles in HIV-1 infected individuals in Ghana.
- Author
-
Nii-Trebi, Nicholas I., Matsuoka, Saori, Kawana-Tachikawa, Ai, Bonney, Evelyn Y., Abana, Christopher Z., Ofori, Sampson B., Mizutani, Taketoshi, Ishizaka, Aya, Shiino, Teiichiro, Ohashi, Jun, Naruse, Taeko K., Kimura, Akinori, Kiyono, Hiroshi, Ishikawa, Koichi, Ampofo, William K., and Matano, Tetsuro
- Subjects
ALLELES ,HIV ,BIOMARKERS ,VIRAL load ,HLA histocompatibility antigens ,NUCLEOTIDE sequencing ,CD4 lymphocyte count - Abstract
Polymorphisms in human leukocyte antigen (HLA) class I loci are known to have a great impact on disease progression in HIV-1 infection. Prevailing HIV-1 subtypes and HLA genotype distribution are different all over the world, and the HIV-1 and host HLA interaction could be specific to individual areas. Data on the HIV-1 and HLA interaction have been accumulated in HIV-1 subtype B- and C-predominant populations but not fully obtained in West Africa where HIV-1 subtype CRF02_AG is predominant. In the present study, to obtain accurate HLA typing data for analysis of HLA association with disease progression in HIV-1 infection in West African populations, HLA class I (HLA-A, -B, and -C) four-digit allele typing was performed in treatment-naïve HIV-1 infected individuals in Ghana (n = 324) by a super high-resolution single-molecule sequence-based typing (SS-SBT) using next-generation sequencing. Comparison of the SS-SBT-based data with those obtained by a conventional sequencing-based typing (SBT) revealed incorrect assignment of several alleles by SBT. Indeed, HLA-A*23:17, HLA-B*07:06, HLA-C*07:18, and HLA-C*18:02 whose allele frequencies were 2.5%, 0.9%, 4.3%, and 3.7%, respectively, were not determined by SBT. Several HLA alleles were associated with clinical markers, viral load and CD4
+ T-cell count. Of note, the impact of HLA-B*57:03 and HLA-B*58:01, known as protective alleles against HIV-1 subtype B and C infection, on clinical markers was not observed in our cohort. This study for the first time presents SS-SBT-based four-digit typing data on HLA-A, -B, and -C alleles in Ghana, describing impact of HLA on viral load and CD4 count in HIV-1 infection. Accumulation of these data would facilitate high-resolution HLA genotyping, contributing to our understanding of the HIV-1 and host HLA interaction in Ghana, West Africa. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
7. Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From Ghana.
- Author
-
Afum, Theophilus, Asandem, Diana Asema, Asare, Prince, Asante-Poku, Adwoa, Mensah, Gloria Ivy, Musah, Abdul Basit, Opare, David, Taniguchi, Kiyosi, Guinko, Nuhu Muniru, Aphour, Thelma, Arhin, Doris, Ishikawa, Koichi, Matano, Tetsuro, Mizutani, Taketoshi, Asiedu-Bekoe, Franklin, Kiyono, Hiroshi, Anang, Abraham Kwabena, Koram, Kwadwo Ansah, and Yeboah-Manu, Dorothy
- Subjects
AMIKACIN ,DRUG resistance in bacteria ,VIBRIO parahaemolyticus ,BACTERIA ,ESCHERICHIA coli ,HEALTH facilities ,ANTIBIOTICS ,SALMONELLA - Abstract
Diarrheal disease remains a major global health problem particularly in children under 5 years and the emergence of antibiotic-resistant strains of causative pathogens could slow control efforts, particularly in settings where treatment options are limited. This surveillance study conducted in Ghana aimed to determine the prevalence and antimicrobial susceptibility profile of diarrhea-causing bacteria. This was a cross-sectional study carried out in five health facilities in the Ga West Municipality of Ghana between 2017 and 2021. Diarrheic stool samples from patients were collected and cultured on standard differential/selective media and isolates identified by standard biochemical tests, MALDI-TOF assay, and serological analysis. The antibiogram was determined using Kirby-Bauer disk diffusion and Microscan autoScan4 MIC panels which were used for extended-spectrum beta-lactamase (ESBL) detection. Bacteria were isolated from 97.5% (772/792) of stool samples, and 167 of the isolates were diarrheagenic and met our inclusion criteria for antimicrobial resistance (AMR) analysis. These included Escherichia coli (49.1%, 82/167), Salmonella species (23.9%, 40/167), Vibrio species (16.8%, 28/167), and Shigella species (10.2%, 17/167). Among 24 Vibrio species, we observed resistances to cefotaxime (21/24, 87.5%), ceftriaxone (20/24, 83.3%), and ciprofloxacin (6/24, 25%), including four multi-drug resistant isolates. All 13 Vibrio parahaemolyticus isolates were resistant to cefazolin. All 17 Shigella isolates were resistant to tetracycline with resistance to shigellosis drugs such as norfloxacin and ciprofloxacin. Salmonella isolates were highly susceptible to norfloxacin (40/40, 100%) and tetracycline (12/34, 35%). Two ESBL-producing E. coli were also identified with marked susceptibility to gentamicin (66/72, 91.7%) and amikacin (57/72, 79.2%) prescribed in the treatment of E. coli infections. This study showed the different bacteria implicated in diarrhea cases in Ghana and the need for differential diagnoses for better treatment outcomes. Escherichia coli , Shigella , Salmonella , and Vibrio have all been implicated in diarrhea cases in Ghana. The highest prevalence was E. coli and Salmonella with Shigella the least prevalent. Resistance to commonly used drugs found in these isolates may render bacteria infection treatment in the near future nearly impossible. Routine antimicrobial susceptibility testing, effective monitoring, and nationwide surveillance of AMR pathogens should be implemented to curb the increase of antimicrobial resistance in Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen®, for people living with HIV.
- Author
-
Koga, Michiko, Senkoji, Tomoe, Kubota, Megumi, Ishizaka, Aya, Mizutani, Taketoshi, Sedohara, Ayako, Ikeuchi, Kazuhiko, Kikuchi, Tadashi, Adachi, Eisuke, Saito, Makoto, Koibuchi, Tomohiko, Hosomichi, Kazuyoshi, Ohashi, Jun, Kawana‐Tachikawa, Ai, Matano, Tetsuro, Tsutsumi, Takeya, and Yotsuyanagi, Hiroshi
- Subjects
HEPATITIS A vaccines ,HIV-positive persons ,CD4 lymphocyte count ,HIV ,MEN who have sex with men - Abstract
Aim: After the hepatitis A virus (HAV) outbreak among men who have sex with men (MSM) around 2018, the importance of HAV vaccination was emphasized, especially for MSM‐living with human immunodeficiency virus (MSM‐LWHIV). Aimmugen® is licensed and distributed exclusively in Japan. While administration of three doses is recommended, 85% of recipients in the general population were reported to acquire seroprotection after the second dose. In this study, we evaluated the efficacy of two or three vaccine doses along with predictors associated with the response to Aimmugen® in MSM‐LWHIV. Methods: We retrospectively examined anti‐HA‐IgG titers of MSM‐LWHIV vaccinated with Aimmugen® in our hospital. Patients' data were collected from medical records. Results: Between January 2018 and October 2019, 141 subjects whose median age was 46 years old, were examined. All the subjects were on antiretroviral therapy (ART) and the median CD4 count was 615/μL. The acquisition rate of protectable anti‐HA‐IgG titers after the second and third dose was 71.1% and 98.6%, respectively. In 114 subjects whose anti‐HA‐IgG titers were tested after the second‐dose, factors significantly associated with better response were prolonged ART duration and higher CD4 count. The titers of anti‐HA‐IgG after the third dose were higher in those who became seropositive after the second‐dose than those who did not. Conclusions: Three‐dose of Aimmugen® for MSM‐LWHIV was effective while two‐dose was less effective compared to non‐HIV‐infected people. People‐LWHIV with shorter duration of ART and lesser CD4 cell count achieved lower titers of anti‐HA‐IgG and might require an additional vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Nef‐specific CD107a+ CD4+ T‐cell responses in a rhesus macaque (Macaca mulatta) showing partial simian immunodeficiency virus control following passive neutralizing antibody infusion.
- Author
-
Hau, Trang Thi Thu, Kanno, Yoshiaki, Nishizawa, Masako, Nomura, Takushi, Matano, Tetsuro, and Yamamoto, Hiroyuki
- Subjects
SIMIAN immunodeficiency virus ,RHESUS monkeys ,VIRAL antibodies ,T cells ,IMMUNOGLOBULINS - Abstract
Acute‐phase neutralizing antibody (NAb) passive immunization in simian immunodeficiency virus (SIV)‐infected rhesus macaques (Macaca mulatta) can confer stringent viremia control with T‐cell augmentation. In one NAb‐infused SIV partial controller, we identify chronic‐phase Nef‐specific CD107a+ CD4+ T‐cell response maintenance, implicating that NAb infusion modulates long‐term T‐cell responses even within viremic control. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused simian immunodeficiency virus controllers.
- Author
-
Kanno, Yoshiaki, Hau, Trang Thi Thu, Kurokawa, Rise, Nomura, Takushi, Nishizawa, Masako, Matano, Tetsuro, and Yamamoto, Hiroyuki
- Published
- 2021
- Full Text
- View/download PDF
11. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
- Author
-
Miki, Shoji, Sasaki, Hiroaki, Horiuchi, Hiroshi, Miyata, Nobuyuki, Yoshimura, Yukihiro, Miyazaki, Kazuhito, Matsumura, Takayuki, Takahashi, Yoshimasa, Suzuki, Tadaki, Matano, Tetsuro, Kawana-Tachikawa, Ai, and Tachikawa, Natsuo
- Subjects
COVID-19 ,SARS-CoV-2 ,RECEIVER operating characteristic curves ,PUBLIC hospitals - Abstract
Background: This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19 critical condition development and mortality in comparison with other predictive markers and scoring systems. Methods: This is a retrospective cohort study conducted at Yokohama Municipal Citizen's Hospital and National Institute of Infectious Diseases. We recruited adult patients with COVID-19 admitted between March 2020 and January 2021. We compared RNAemia with clinical status on admission including scoring systems such as the 4C Mortality, CURB-65, and A-DROP, as well as the C
t value of the nasopharyngeal PCR, in predicting COVID-19 mortality and critical condition development. Results: Of the 92 recruited patients (median age, 58; interquartile range, 45–71 years), 14 (14.9%) had RNAemia. These patients had an older age (median, 68 years vs. 55.5 years; p = 0.011), higher values of lactated dehydrogenase (median, 381 U/L vs. 256.5 U/L, p < 0.001), C-reactive protein (median, 10.9 mg/dL vs. 3.8 mg/dL; p < 0.001), D-dimer (median, 2.07 μg/mL vs. 1.28 μg/mL; p = 0.015), lower values of lymphocyte (median, 802/μL vs. 1007/μL, p = 0.025) and Ct of the nasopharyngeal PCR assay (median, 20.59 vs. 25.54; p = 0.021) than those without RNAemia. Univariate analysis showed RNAemia was associated with mortality (odds ratio [OR], 18.75; 95% confidence interval [CI], 3.92–89.76; area under the receiver operating characteristic curve [AUC], 0.7851; p = 0.002) and critical condition (OR, 72.00; 95% CI, 12.98–399.29; AUC, 0.8198; p < 0.001). Plus, multivariate analysis also revealed the association of RNAemia with critical condition (adjusted OR, 125.71; 95% CI, 11.47–1377.32; p < 0.001). Conclusion: On-admission SARS-CoV-2 RNAemia is a potent predictive marker of COVID-19 critical condition and mortality. The adjusted OR for critical condition was as high as 125.71. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
12. Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritis.
- Author
-
Mizutani, Taketoshi, Aboagye, Samuel Yaw, Ishizaka, Aya, Afum, Theophillus, Mensah, Gloria Ivy, Asante-Poku, Adwoa, Asandem, Diana Asema, Parbie, Prince Kofi, Abana, Christopher Zaab-Yen, Kushitor, Dennis, Bonney, Evelyn Yayra, Adachi, Motoi, Hori, Hiroki, Ishikawa, Koichi, Matano, Tetsuro, Taniguchi, Kiyosu, Opare, David, Arhin, Doris, Asiedu-Bekoe, Franklin, and Ampofo, William Kwabena
- Subjects
GUT microbiome ,VIRAL gastroenteritis ,CARBOHYDRATE metabolism ,ROTAVIRUS diseases ,DIAGNOSIS of diarrhea ,RIBOSOMAL RNA ,DYSBIOSIS - Abstract
Acute gastroenteritis associated with diarrhea is considered a serious disease in Africa and South Asia. In this study, we examined the trends in the causative pathogens of diarrhea and the corresponding gut microbiota in Ghana using microbiome analysis performed on diarrheic stools via 16S rRNA sequencing. In total, 80 patients with diarrhea and 34 healthy adults as controls, from 2017 to 2018, were enrolled in the study. Among the patients with diarrhea, 39 were norovirus-positive and 18 were rotavirus-positive. The analysis of species richness (Chao1) was lower in patients with diarrhea than that in controls. Beta-diversity analysis revealed significant differences between the two groups. Several diarrhea-related pathogens (e.g., Escherichia-Shigella, Klebsiella and Campylobacter) were detected in patients with diarrhea. Furthermore, co-infection with these pathogens and enteroviruses (e.g., norovirus and rotavirus) was observed in several cases. Levels of both Erysipelotrichaceae and Staphylococcaceae family markedly differed between norovirus-positive and -negative diarrheic stools, and the 10 predicted metabolic pathways, including the carbohydrate metabolism pathway, showed significant differences between rotavirus-positive patients with diarrhea and controls. This comparative study of diarrheal pathogens in Ghana revealed specific trends in the gut microbiota signature associated with diarrhea and that pathogen-dependent dysbiosis occurred in viral gastroenteritis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Dysbiotic Fecal Microbiome in HIV-1 Infected Individuals in Ghana.
- Author
-
Parbie, Prince Kofi, Mizutani, Taketoshi, Ishizaka, Aya, Kawana-Tachikawa, Ai, Runtuwene, Lucky Ronald, Seki, Sayuri, Abana, Christopher Zaab-Yen, Kushitor, Dennis, Bonney, Evelyn Yayra, Ofori, Sampson Badu, Uematsu, Satoshi, Imoto, Seiya, Kimura, Yasumasa, Kiyono, Hiroshi, Ishikawa, Koichi, Ampofo, William Kwabena, and Matano, Tetsuro
- Subjects
HIV ,AIDS ,MEN who have sex with men ,GUT microbiome - Abstract
HIV-1 infected individuals under antiretroviral therapy can control viremia but often develop non-AIDS diseases such as cardiovascular and metabolic disorders. Gut microbiome dysbiosis has been indicated to be associated with progression of these diseases. Analyses of gut/fecal microbiome in individual regions are important for our understanding of pathogenesis in HIV-1 infections. However, data on gut/fecal microbiome has not yet been accumulated in West Africa. In the present study, we examined fecal microbiome compositions in HIV-1 infected adults in Ghana, where approximately two-thirds of infected adults are females. In a cross-sectional case-control study, age- and gender-matched HIV-1 infected adults (HIV+; n = 55) and seronegative controls (HIV-; n = 55) were enrolled. Alpha diversity of fecal microbiome in HIV+ was significantly reduced compared to HIV- and associated with CD4 counts. HIV+ showed reduction in varieties of bacteria including Faecalibacterium , the most abundant in seronegative controls, but enrichment of Proteobacteria. Ghanaian HIV+ exhibited enrichment of Dorea and Blautia ; bacteria groups whose depletion has been reported in HIV-1 infected individuals in several other cohorts. Furthermore, HIV+ in our cohort exhibited a depletion of Prevotella , a genus whose enrichment has recently been shown in men having sex with men (MSM) regardless of HIV-1 status. The present study revealed the characteristics of dysbiotic fecal microbiome in HIV-1 infected adults in Ghana, a representative of West African populations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Development and evaluation of a rapid and cost-efficient NGS-based MHC class I genotyping method for macaques by using a prevalent short-read sequencer.
- Author
-
Tanimoto, Kousuke, Naruse, Taeko K., Matano, Tetsuro, and Kimura, Akinori
- Abstract
Rhesus macaque is one of the most widely used primate model animals for immunological research of infectious diseases including human immunodeficiency virus (HIV) infection. It is well known that major histocompatibility complex (MHC) class I genotypes affect the susceptibility and disease progression to simian immunodeficiency virus (SIV) in rhesus macaques, which is resembling to HIV in humans. It is required to convincingly determine the MHC genotypes in the immunological investigations, that is why several next-generation sequencing (NGS)-based methods have been established. In general, NGS-based genotyping methods using short amplicons are not often applied to MHC because of increasing number of alleles and inevitable ambiguity in allele detection, although there is an advantage of short read sequencing systems that are commonly used today. In this study, we developed a new high-throughput NGS-based genotyping method for MHC class I alleles in rhesus macaques and cynomolgus macaques. By using our method, 95% and 100% of alleles identified by PCR cloning-based method were detected in rhesus macaques and cynomolgus macaques, respectively, which were highly correlated with their expression levels. It was noted that the simulation of new-allele detection step using artificial alleles differing by a few nucleotide sequences from a known allele could be identified with high accuracy and that we could detect a real novel allele from a rhesus macaque sample. These findings supported that our method could be adapted for primate animal models such as macaques to reduce the cost and labor of previous NGS-based MHC genotyping. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Immunophenotyping of Rhesus CMV‐Specific CD8 T‐Cell Populations.
- Author
-
Pomplun, Nicholas L., Vosler, Logan, Weisgrau, Kim L., Furlott, Jessica, Weiler, Andrea M., Abdelaal, Hadia M., Evans, David T., Watkins, David I., Matano, Tetsuro, Skinner, Pamela J., Friedrich, Thomas C., and Rakasz, Eva G.
- Abstract
A vaccine to ameliorate cytomegalovirus (CMV)‐related pathogenicity in transplantation patients is considered a top priority. A therapeutic vaccine must include components that elicit both neutralizing antibodies, and highly effective CD8 T‐cell responses. The most important translational model of vaccine development is the captive‐bred rhesus macaque (Macaca mulatta) of Indian origin. There is a dearth of information on rhesus cytomegalovirus (rhCMV)‐specific CD8 T cells due to the absence of well‐defined CD8 T‐cell epitopes presented by classical MHC‐I molecules. In the current study, we defined two CD8 T‐cell epitopes restricted by high‐frequency Mamu alleles: the Mamu‐A1*002:01 restricted VY9 (VTTLGMALY aa291‐299) epitope of protein IE‐1, and the Mamu‐A1*008:01 restricted NP8 (NPTDRPIP aa96‐103) epitope of protein phosphoprotein 65‐2. We developed tetramers and determined the level, phenotype, and functional capability of the two epitope‐specific T‐cell populations in circulation and various tissues. We demonstrated the value of these tetramers for in situ tetramer staining. Here, we first provided critical reagents and established a flow cytometric staining strategy to study rhCMV‐specific T‐cell responses in up to 40% of captive‐bred rhesus macaques. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Gut-Homing CD4+ T Cells Are Associated with the Activity of Gastritis in HIV-Infected Adults.
- Author
-
Sato, Hidenori, Ota, Yasunori, Kido, Yasutoshi, Matsumoto, Takashi, Matsubara, Yasuo, Matano, Tetsuro, Hirata, Yoshihiro, Kawana-Tachikawa, Ai, Yamaoka, Yoshio, Yotsuyanagi, Hiroshi, and Adachi, Eisuke
- Published
- 2020
- Full Text
- View/download PDF
17. Therapeutic vaccine-mediated Gag-specific CD8+ T-cell induction under anti-retroviral therapy augments anti-virus efficacy of CD8+ cells in simian immunodeficiency virus-infected macaques.
- Author
-
Nakamura-Hoshi, Midori, Takahara, Yusuke, Matsuoka, Saori, Ishii, Hiroshi, Seki, Sayuri, Nomura, Takushi, Yamamoto, Hiroyuki, Sakawaki, Hiromi, Miura, Tomoyuki, Tokusumi, Tsuyoshi, Shu, Tsugumine, and Matano, Tetsuro
- Subjects
THERAPEUTICS ,VACCINES ,SENDAI virus ,LYMPHOCYTES ,SIMIAN immunodeficiency virus - Abstract
Anti-retroviral therapy (ART) can inhibit HIV proliferation but not achieve virus eradication from HIV-infected individuals. Under ART-based HIV control, virus-specific CD8
+ T-cell responses are often reduced. Here, we investigated the impact of therapeutic vaccination inducing virus-specific CD8+ T-cell responses under ART on viral control in a macaque AIDS model. Twelve rhesus macaques received ART from week 12 to 32 after simian immunodeficiency virus (SIV) infection. Six of them were vaccinated with Sendai virus vectors expressing SIV Gag and Vif at weeks 26 and 32, and Gag/Vif-specific CD8+ T-cell responses were enhanced and became predominant. All macaques controlled viremia during ART but showed viremia rebound after ART cessation. Analysis of in vitro CD8+ cell ability to suppress replication of autologous lymphocytes-derived SIVs found augmentation of anti-SIV efficacy of CD8+ cells after vaccination. In the vaccinated animals, the anti-SIV efficacy of CD8+ cells at week 34 was correlated positively with Gag-specific CD8+ T-cell frequencies and inversely with rebound viral loads at week 34. These results indicate that Gag-specific CD8+ T-cell induction by therapeutic vaccination can augment anti-virus efficacy of CD8+ cells, which may be insufficient for functional cure but contribute to more stable viral control under ART. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.
- Author
-
Seki, Sayuri, Nomura, Takushi, Nishizawa, Masako, Yamamoto, Hiroyuki, Ishii, Hiroshi, Matsuoka, Saori, Shiino, Teiichiro, Sato, Hironori, Mizuta, Kazuta, Sakawaki, Hiromi, Miura, Tomoyuki, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
MICROBIAL virulence ,PATHOGENIC microorganisms ,HISTOCOMPATIBILITY antigens ,CELL lines ,HIV infections - Abstract
CD8
+ T-cell responses exert strong suppressive pressure on HIV replication and select for viral escape mutations. Some of these major histocompatibility complex class I (MHC-I)-associated mutations result in reduction of in vitro viral replicative capacity. While these mutations can revert after viral transmission to MHC-I-disparate hosts, recent studies have suggested that these MHC-I-associated mutations accumulate in populations and make viruses less pathogenic in vitro. Here, we directly show an increase in the in vivo virulence of an MHC-I-adapted virus serially-passaged through MHC-I-mismatched hosts in a macaque AIDS model despite a reduction in in vitro viral fitness. The first passage simian immunodeficiency virus (1pSIV) obtained 1 year after SIVmac239 infection in a macaque possessing a protective MHC-I haplotype 90-120-Ia was transmitted into 90-120-Ia- macaques, whose plasma 1 year post-infection was transmitted into other 90-120-Ia- macaques to obtain the third passage SIV (3pSIV). Most of the 90-120-Ia-associated mutations selected in 1pSIV did not revert even in 3pSIV. 3pSIV showed lower in vitro viral fitness but induced persistent viremia in 90-120-Ia- macaques. Remarkably, 3pSIV infection in 90-120-Ia+ macaques resulted in significantly higher viral loads and reduced survival compared to wild-type SIVmac239. These results indicate that MHC-I-adapted SIVs serially-transmitted through MHC-I-mismatched hosts can have higher virulence in MHC-I-matched hosts despite their lower in vitro viral fitness. This study suggests that multiply-passaged HIVs could result in loss of HIV-specific CD8+ T cell responses in human populations and the in vivo pathogenic potential of these escaped viruses may be enhanced. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
19. Augmentation of anti-simian immunodeficiency virus activity in CD8+ cells by neutralizing but not nonneutralizing antibodies in the acute phase.
- Author
-
Hiroyuki Yamamoto, Sumire Iseda, Taku Nakane, Takushi Nomura, Naofumi Takahashi, Sayuri Seki, Midori Nakamura, Hiroshi Ishii, Tetsuro Matano, Yamamoto, Hiroyuki, Iseda, Sumire, Nakane, Taku, Nomura, Takushi, Takahashi, Naofumi, Seki, Sayuri, Nakamura, Midori, Ishii, Hiroshi, and Matano, Tetsuro
- Published
- 2016
- Full Text
- View/download PDF
20. Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses.
- Author
-
Seki, Sayuri and Matano, Tetsuro
- Abstract
Virus-specific CD8+T-cell responses play a major role in the control of HIV replication, and induction of HIV-specific T-cell responses is an important strategy for AIDS vaccine development. Optimization of the delivery system and immunogen would be the key for the development of an effective T cell-based AIDS vaccine. Heterologous prime-boost vaccine regimens using multiple viral vectors are a promising protocol for efficient induction of HIV-specific T-cell responses, and the development of a variety of potent viral vectors have been attempted. This review describes the current progress of the development of T cell-based AIDS vaccines using viral vectors, focusing on Sendai virus vectors, whose phase I clinical trials have been performed. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
21. Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.
- Author
-
Nomura, Takushi, Yamamoto, Hiroyuki, Ishii, Hiroshi, Akari, Hirofumi, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
CD8 antigen ,CD antigens ,T cells ,LYMPHOCYTES ,VIRAL replication - Abstract
Control of HIV replication is a rare immunological event, providing clues to understand the viral control mechanism. CD8
+ T-cell responses are crucial for virus control, but it is unclear whether lasting HIV containment can be achieved after establishment of infection. Here, we describe lasting SIV containment in a macaque AIDS model. Analysis of ten rhesus macaques that controlled viremia for 2 years post-infection found accumulation of proviral gag and nef CD8+ T-cell escape mutations in four of them. These four controllers mounted CD8+ T cells targeting Gag, Nef, and other viral proteins at 4 months, suggesting that broadening of CD8+ T-cell targets can be an indicator of the beginning of viral control failure. The remaining six aviremic SIV controllers, however, harbored proviruses without mutations and showed no or little broadening of their CD8+ T-cell responses in the chronic phase. Indeed, three of the latter six exhibiting no change in CD8+ T-cell targets showed gradual decreases in SIV-specific CD8+ T-cell frequencies, implying a concomitant reduction in viral replication. Thus, stability of the breadth of virus-specific CD8+ T-cell responses may represent a status of lasting HIV containment by CD8+ T cells. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
22. Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.
- Author
-
Nishizawa, Masako, Matsuda, Masakazu, Hattori, Junko, Shiino, Teiichiro, Matano, Tetsuro, Heneine, Walid, Johnson, Jeffrey A., and Sugiura, Wataru
- Subjects
SALVAGE therapy ,DRUG resistance ,HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,DISEASE prevalence ,VIREMIA - Abstract
Background: Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequencing due to the ability to detect low-frequency variants. To clarify a clinical benefit to monitoring minority-level drug resistance populations as a guide to select active drugs for salvage therapy, we retrospectively analyzed the dynamics of low-frequency drug-resistant population in antiretroviral (ARV)-exposed drug resistant individuals. Materials and Methods: Six HIV-infected individuals treated with ARV for more than five years were analyzed. These individuals had difficulty in controlling viremia, and treatment regimens were switched multiple times guided by standard drug resistance testing using bulk sequencing. To detect minority variant populations with drug resistance, we used a highly sensitive allele-specific PCR (AS-PCR) with detection thresholds of 0.3–2%. According to ARV used in these individuals, we focused on the following seven reverse transcriptase inhibitor-resistant mutations: M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y. Results of AS-PCR were compared with bulk sequencing data for concordance and presence of additional mutations. To clarify the genetic relationship between low-frequency and high-frequency populations, AS-PCR amplicon sequences were compared with bulk sequences in phylogenetic analysis. Results: The use of AS-PCR enabled detection of the drug-resistant mutations, M41L, K103N, Y181C, M184V and T215Y, present as low-frequency populations in five of the six individuals. These drug resistant variants persisted for several years without ARV pressure. Phylogenetic analysis indicated that pre-existing K103N and T215I variants had close genetic relationships with high-frequency K103N and T215I observed during treatment. Discussion and Conclusion: Our results demonstrate the long-term persistence of drug-resistant viruses in the absence of drug pressure. The rapid virologic failures with pre-existing mutant viruses detectable by AS-PCR highlight the clinical importance of low-frequency drug-resistant viruses. Thus, our results highlight the usefulness of AS-PCR and support its expanded evaluation in ART clinical management. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
23. Development of Vaccines Using SeV Vectors Against AIDS and Other Infectious Diseases.
- Author
-
Seki, Sayuri and Matano, Tetsuro
- Published
- 2013
- Full Text
- View/download PDF
24. Divergence and diversity of ULBP2 genes in rhesus and cynomolgus macaques.
- Author
-
Naruse, Taeko, Akari, Hirofumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
BIOLOGICAL divergence ,RHESUS monkeys ,KRA ,MEDICAL research ,CHROMOSOME duplication ,GENETIC polymorphisms ,NUCLEOTIDE sequence - Abstract
Non-human primates such as rhesus macaque and cynomolgus macaque are important animals for medical research fields and they are classified as Old World monkey, in which genome structure is characterized by gene duplications. In the present study, we investigated polymorphisms in two genes for ULBP2 molecules that are ligands for NKG2D. A total of 15 and 11 ULBP2.1 alleles and 11 and 10 ULBP2.2 alleles were identified in rhesus macaques and cynomolgus macaques, respectively. Nucleotide sequences of exons for extra cellular domain were highly polymorphic and more than 70 % were non-synonymous variations in both ULBP2.1 and ULBP2.2. In addition, phylogenetic analyses revealed that the ULBP2.2 was diverged from a branch of ULBP2.1 along with ULBP2s of higher primates. Moreover, when 3D structural models were constructed for the rhesus ULBP2 molecules, residues at presumed contact sites with NKG2D were polymorphic in ULBP2.1 and ULBP2.2 in the rhesus macaque and cynomolgus macaque, respectively. These observations suggest that amino acid replacements at the interaction sites with NKG2D might shape a specific nature of ULBP2 molecules in the Old World monkeys. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. A Novel Protective MHC-I Haplotype Not Associated with Dominant Gag-Specific CD8+ T-Cell Responses in SIVmac239 Infection of Burmese Rhesus Macaques.
- Author
-
Takahashi, Naofumi, Nomura, Takushi, Takahara, Yusuke, Yamamoto, Hiroyuki, Shiino, Teiichiro, Takeda, Akiko, Inoue, Makoto, Iida, Akihiro, Hara, Hiroto, Shu, Tsugumine, Hasegawa, Mamoru, Sakawaki, Hiromi, Miura, Tomoyuki, Igarashi, Tatsuhiko, Koyanagi, Yoshio, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
HLA histocompatibility antigens ,MAJOR histocompatibility complex ,HIV ,HIV infections ,GENETIC polymorphisms ,TRANSPLANTATION immunology ,EPITOPES - Abstract
Several major histocompatibility complex class I (MHC-I) alleles are associated with lower viral loads and slower disease progression in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Immune-correlates analyses in these MHC-I-related HIV/SIV controllers would lead to elucidation of the mechanism for viral control. Viral control associated with some protective MHC-I alleles is attributed to CD8
+ T-cell responses targeting Gag epitopes. We have been trying to know the mechanism of SIV control in multiple groups of Burmese rhesus macaques sharing MHC-I genotypes at the haplotype level. Here, we found a protective MHC-I haplotype, 90-010-Id (D), which is not associated with dominant Gag-specific CD8+ T-cell responses. Viral loads in five D+ animals became significantly lower than those in our previous cohorts after 6 months. Most D+ animals showed predominant Nef-specific but not Gag-specific CD8+ T-cell responses after SIV challenge. Further analyses suggested two Nef-epitope-specific CD8+ T-cell responses exerting strong suppressive pressure on SIV replication. Another set of five D+ animals that received a prophylactic vaccine using a Gag-expressing Sendai virus vector showed significantly reduced viral loads compared to unvaccinated D+ animals at 3 months, suggesting rapid SIV control by Gag-specific CD8+ T-cell responses in addition to Nef-specific ones. These results present a pattern of SIV control with involvement of non-Gag antigen-specific CD8+ T-cell responses. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
26. Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates.
- Author
-
Ohtani, Hitoshi, Naruse, Taeko, Iwasaki, Yuki, Akari, Hirofumi, Ishida, Takafumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
T cells ,IMMUNOGLOBULINS ,MUCIN genetics ,PRIMATE physiology ,IMMUNE response ,NATURAL selection ,MOLECULAR evolution ,PSEUDOGENES - Abstract
T-cell immunoglobulin domain and mucin domain containing protein 1 (TIM1), also known as a cellular receptor for hepatitis A virus (HAVCR1) or a molecule induced by ischemic injury in the kidney (KIM1), is involved in the regulation of immune responses. We investigated a natural selection history of TIM1 by comparative sequencing analysis in 24 different primates. It was found that TIM1 had become a pseudogene in multiple lineages of the New World monkey. We also investigated T cell lines originated from four different New World monkey species and confirmed that TIM1 was not expressed at the mRNA level. On the other hand, there were ten amino acid sites in the Ig domain of TIM1 in the other primates, which were suggested to be under positive natural selection. In addition, mucin domain of TIM1 was highly polymorphic in the Old World monkeys, which might be under balanced selection. These data suggested that TIM1 underwent a lineage-specific evolutionary pathway in the primates. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
27. Phylodynamic inference of infectious diseases caused by HIV, enterovirus 71 and the 2009 swine-origin human influenza virus.
- Author
-
Tee, Kok Keng, Kamarulzaman, Adeeba, Matano, Tetsuro, and Takebe, Yutaka
- Published
- 2012
- Full Text
- View/download PDF
28. Diversity of MHC class I haplotypes in cynomolgus macaques.
- Author
-
Saito, Yusuke, Naruse, Taeko, Akari, Hirofumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
IMMUNE response ,MAJOR histocompatibility complex ,HAPLOTYPES ,KRA ,ANIMAL models of immunological tolerance ,GENE frequency ,LOCUS (Genetics) - Abstract
Cynomolgus macaques are widely used as a primate model for human diseases associated with an immunological process. Because there are individual differences in immune responsiveness, which are controlled by the polymorphic nature of the major histocompatibility (MHC) locus, it is important to reveal the diversity of MHC in the model animal. In this study, we analyzed 26 cynomolgus macaques from five families for MHC class I genes. We identified 32 Mafa-A, 46 Mafa-B, 6 Mafa-I, and 3 Mafa-AG alleles in which 14, 20, 3, and 3 alleles were novel. There were 23 MHC class I haplotypes and each haplotype was composed of one to three Mafa-A alleles and one to five Mafa-B alleles. Family studies revealed that there were two haplotypes which contained two Mafa-A1 alleles. These observations demonstrated further the complexity of MHC class I locus in the Old World monkey. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
29. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.
- Author
-
Nakamura, Midori, Takahara, Yusuke, Ishii, Hiroshi, Sakawaki, Hiromi, Horiike, Mariko, Miura, Tomoyuki, Igarashi, Tatsuhiko, Naruse, Taeko K., Kimura, Akinori, Matano, Tetsuro, and Matsuoka, Saori
- Subjects
HISTOCOMPATIBILITY ,LYMPHOCYTES ,SIMIAN immunodeficiency virus ,LABORATORY monkeys ,EPITOPES ,VACCINATION ,ANTIGENS - Abstract
ABSTRACT Major histocompatibility complex class I (MHC-I)-restricted CD8
+ cytotoxic T lymphocyte (CTL) responses are crucial for the control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication. In particular, Gag-specific CTL responses have been shown to exert strong suppressive pressure on HIV/SIV replication. Additionally, association of Vif-specific CTL frequencies with in vitro anti-SIV efficacy has been suggested recently. Host MHC-I genotypes could affect the immunodominance patterns of these potent CTL responses. Here, Gag- and Vif-specific CTL responses during primary SIVmac239 infection were examined in three groups of Burmese rhesus macaques, each group having a different MHC-I haplotype. The first group of four macaques, which possessed the MHC-I haplotype 90-010-Ie, did not show Gag- or Vif-specific CTL responses. However, Nef-specific CTL responses were elicited, suggesting that primary SIV infection does not induce predominant CTL responses specific for Gag/Vif epitopes restricted by 90-010-Ie-derived MHC-I molecules. In contrast, Gag- and Vif-specific CTL responses were induced in the second group of two 89-075-Iw-positive animals and the third group of two 91-010-Is-positive animals. Considering the potential of prophylactic vaccination to affect CTL immunodominance post-viral exposure, these groups of macaques would be useful for evaluation of vaccine antigen-specific CTL efficacy against SIV infection. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
30. ULBP4/RAET1E is highly polymorphic in the Old World monkey.
- Author
-
Naruse, Taeko, Okuda, Yukiko, Mori, Kazuyasu, Akari, Hirofumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
IMMUNOGENETICS ,KRA ,RHESUS monkeys ,IMMUNE response ,GENETIC polymorphisms ,MONOCLONAL antibodies ,T cells ,ANIMAL models in research - Abstract
Natural-killer group 2 member D (NKG2D) is an activating receptor that plays an important role in the immune response mediated by NK cells, γδ T cells, and CD8 T cells. In humans, MHC class I chain-related genes and UL-16 binding protein (ULBP)/retinoic acid early transcript 1 (REAT1) gene family encode ligands for NKG2D. The rhesus and crab-eating macaques, which belong to the Old World monkeys, are widely used as non-human primate models in medical researches on the immunological process. In the present study, we investigated the polymorphisms of ULBP4/ RAET1E, a member of the ULBP/RAET1 family, and found 25 and 14 alleles from the rhesus and crab-eating macaques, respectively, of which diversities were far more extended than in humans. A phylogenetic study suggested that the allelic diversification of ULBP4/RAET1E predated the divergence of rhesus and crab-eating macaques. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
31. Broadening of CD8+ cell responses in vaccine-based simian immunodeficiency virus controllers.
- Author
-
Iwamoto, Nami, Tsukamoto, Tetsuo, Kawada, Miki, Takeda, Akiko, Yamamoto, Hiroyuki, Takeuchi, Hiroaki, and Matano, Tetsuro
- Published
- 2010
- Full Text
- View/download PDF
32. Diversity of MHC class I genes in Burmese-origin rhesus macaques.
- Author
-
Naruse, Taeko K., Zhiyong Chen, Yanagida, Risa, Yamashita, Tomoko, Saito, Yusuke, Mori, Kazuyasu, Akari, Hirofumi, Yasutomi, Yasuhiro, Miyazawa, Masaaki, Matano, Tetsuro, and Kimura, Akinori
- Subjects
VACCINATION ,HIV ,SIV antibodies ,MAJOR histocompatibility complex ,IMMUNE system ,RHESUS monkeys ,IMMUNODEFICIENCY ,MACAQUES - Abstract
Rhesus macaques ( Macaca mulatta) are widely used in developing a strategy for vaccination against human immunodeficiency virus by using simian immunodeficiency virus infection as a model system. Because the genome diversity of major histocompatibility complex (MHC) is well known to control the immune responsiveness to foreign antigens, MHC loci in Indian- and Chinese-origin macaques used in the experiments have been characterized, and it was revealed that the diversity of MHC in macaques was larger than the human MHC. To further characterize the diversity of Mamu-A and Mamu-B loci, we investigated a total of 73 different sequences of Mamu-A, 83 sequences of Mamu-B, and 15 sequences of Mamu-I cDNAs isolated from Burmese-origin macaques. It was found that there were one to five expressing genes in each locus. Among the Mamu-A, Mamu-B, and Mamu-I sequences, 44 (60.2%), 45 (54.2%), and 8 (53.3%), respectively, were novel, and most of the other known alleles were identical to those reported from Chinese- or Indian-origin macaques, demonstrating a genetic mixture between the geographically distinct populations of present day China and India. In addition, it was found that a Mamu haplotype contained at least two highly transcribed Mamu-A genes, because multiple Mamu-A1 cDNAs were obtained from one haplotype. These findings further revealed the diversity and complexity of MHC locus in the rhesus macaques. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
33. A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins.
- Author
-
Inagaki, Natsuko, Takeuchi, Hiroaki, Yokoyama, Masaru, Sato, Hironori, Ryo, Akihide, Yamamoto, Hiroyuki, Kawada, Miki, and Matano, Tetsuro
- Subjects
SIMIAN immunodeficiency virus ,SIMIAN viruses ,IMMUNODEFICIENCY ,IMMUNITY ,IMMUNOSUPPRESSION - Abstract
Background: The Gag capsid (CA) is one of the most conserved proteins in highly-diversified human and simian immunodeficiency viruses (HIV and SIV). Understanding the limitations imposed on amino acid sequences in CA could provide valuable information for vaccine immunogen design or anti-HIV drug development. Here, by comparing two pathogenic SIV strains, SIVmac239 and SIVsmE543-3, we found critical amino acid residues for functional interaction between the N-terminal and the C-terminal domains in CA. Results: We first examined the impact of Gag residue 205, aspartate (Gag205D) in SIVmac239 and glutamate (Gag205E) in SIVsmE543-3, on viral replication; due to this difference, Gag
206-216 (IINEEAADWDL) epitope-specific cytotoxic T lymphocytes (CTLs) were previously shown to respond to SIVmac239 but not SIVsmE543-3 infection. A mutant SIVmac239, SIVmac239Gag205E, whose Gag205D is replaced with Gag205E showed lower replicative ability. Interestingly, however, SIVmac239Gag205E passaged in macaque T cell culture often resulted in selection of an additional mutation at Gag residue 340, a change from SIVmac239 valine (Gag340V) to SIVsmE543-3 methionine (Gag340M), with recovery of viral fitness. Structural modeling analysis suggested possible intermolecular interaction between the Gag205 residue in the N-terminal domain and Gag340 in the C-terminal in CA hexamers. The Gag205D-to-Gag205E substitution in SIVmac239 resulted in loss of in vitro core stability, which was recovered by additional Gag340V-to-Gag340M substitution. Finally, selection of Gag205E plus Gag340M mutations, but not Gag205E alone was observed in a chronically SIVmac239-infected rhesus macaque eliciting Gag206-216 -specific CTL responses. Conclusions: These results present in vitro and in vivo evidence implicating the interaction between Gag residues 205 in CA NTD and 340 in CA CTD in SIV replication. Thus, this study indicates a structural constraint for functional interaction between SIV CA NTD and CTD, providing insight into immunogen design to limit viral escape options. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
34. Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus.
- Author
-
Ishizaka, Aya, Koga, Michiko, Mizutani, Taketoshi, Lim, Lay Ahyoung, Adachi, Eisuke, Ikeuchi, Kazuhiko, Ueda, Ryuta, Aoyagi, Haruyo, Tanaka, Satoshi, Kiyono, Hiroshi, Matano, Tetsuro, Aizaki, Hideki, Yoshio, Sachiyo, Mita, Eiji, Muramatsu, Masamichi, Kanto, Tatsuya, Tsutsumi, Takeya, and Yotsuyanagi, Hiroshi
- Subjects
HIV ,HEPATITIS A virus ,DYSBIOSIS ,VIRAL hepatitis ,HEPATITIS viruses ,GUT microbiome ,INTESTINAL mucosa ,FECES - Abstract
Hepatitis A virus (HAV) causes transient acute infection, and little is known of viral shedding via the duodenum and into the intestinal environment, including the gut microbiome, from the period of infection until after the recovery of symptoms. Therefore, in this study, we aimed to comprehensively observe the amount of virus excreted into the intestinal tract, the changes in the intestinal microbiome, and the level of inflammation during the healing process. We used blood and stool specimens from patients with human immunodeficiency virus who were infected with HAV during the HAV outbreak in Japan in 2018. Moreover, we observed changes in fecal HAV RNA and quantified the plasma cytokine level and gut microbiome by 16S rRNA analysis from clinical onset to at least 6 months after healing. HAV was detected from clinical onset up to a period of more than 150 days. Immediately after infection, many pro-inflammatory cytokines were elicited, and some cytokines showed different behaviors. The intestinal microbiome changed significantly after infection (dysbiosis), and the dysbiosis continued for a long time after healing. These observations suggest that the immunocompromised state is associated with prolonged viral shedding into the intestinal tract and delayed recovery of the intestinal environment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Anti-HIV adaptive immunity: determinants for viral persistence.
- Author
-
Yamamoto, Hiroyuki and Matano, Tetsuro
- Abstract
The immense difficulty in primary control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection by adaptive immune responses has been a topic of exceptional importance. CD8
+ cytotoxic T lymphocytes (CTLs) do play a central role in primary resolution of viremia, but their potency in viral control is generally constrained in the natural courses of HIV/SIV infections. The overall repertoire of CTLs is dependent on both the host and the virus genetic polymorphisms, and the potency of each individual CTL is affected by immunological and virological determinants. HIV/SIV infections lack early appearance of neutralising antibodies (NAbs), and our recent finding has suggested a possibility of their absence contributing to diminished virus-specific CD4+ T-cell responses leading to failure in primary viral control. Extrapolations from studies in macaque models of SIV infection and analyses of the cohorts of HIV control in humans have to date delineated the numerous requirements for attainment of viral control. Understanding of the individual components of adaptive immune responses and their optimal concert required for HIV/SIV control would contribute to development of an effective AIDS vaccine. Here, we discuss current insights into CTLs and NAbs, and speculate their possible protective mechanism against establishment of persistent HIV/SIV infection. Copyright © 2008 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
36. Host factors involved in resistance to retroviral infection.
- Author
-
Takeuchi, Hiroaki and Matano, Tetsuro
- Subjects
RETROVIRUS diseases ,VIRUS diseases ,IMMUNITY ,CYCLOPHILINS ,VIRAL replication - Abstract
Viral replication requires the help of host cell factors, whose species specificity may affect viral tropism. On the other hand, there exist host factors that restrict viral replication. The anti-viral system mediated by some of these restriction factors, which is termed intrinsic immunity and is distinguished from conventional innate and adaptive immunity, has been described as playing an important role in making species-specific barriers against viral infection. Here, we describe the current progress in understanding of such restriction factors against retroviral replication, focusing on TRIM5α and APOBEC, whose anti-retroviral effects have recently been recognized. Additionally, we mention cyclophilin A, which is essential for HIV-1 replication in human cells and may affect viral tropism. Understanding of these host factors would contribute to identification of the determinants for viral tropism. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
37. Reference strand-mediated conformation analysis-based typing of multiple alleles in the rhesus macaque MHC class I Mamu-A and Mamu-B loci.
- Author
-
Tanaka-Takahashi, Yumiko, Yasunami, Michio, Naruse, Taeko, Hinohara, Kunihiko, Matano, Tetsuro, Mori, Kazuyasu, Miyazawa, Masaaki, Honda, Mitsuo, Yasutomi, Yasuhiro, Nagai, Yoshiyuki, and Kimura, Akinori
- Published
- 2007
- Full Text
- View/download PDF
38. Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Neutralization-Resistant SIVsmE543-3 Infection.
- Author
-
Nomura, Yuto, Matsuoka, Saori, Okazaki, Midori, Kuwata, Takeo, Matano, Tetsuro, and Ishii, Hiroshi
- Subjects
IMMUNOGLOBULIN genes ,GENETIC polymorphisms ,B cell receptors ,GERM cells ,VACCINE effectiveness ,IMMUNOGLOBULINS ,NEUTRALIZATION tests - Abstract
Antibody responses are crucial for the control of virus infection. Understanding of the mechanism of antibody induction is important for the development of a vaccine eliciting effective anti-virus antibodies. Virus-specific B cell receptor (BCR)/antibody repertoires are different among individuals, but determinants for this difference remain largely unclear. We have recently reported that a germline BCR immunoglobulin (IgG) gene polymorphism (VH3.33_ET or VH3.33_VI) in rhesus macaques is the determinant for induction of potent B404-class anti-simian immunodeficiency virus (SIV) neutralizing antibodies in neutralization-sensitive SIVsmH635FC infection. In the present study, we examined whether neutralization-resistant SIVsmE543-3 infection can induce the anti-SIV neutralizing antibodies associated with the germline VH3.33 polymorphism. Anti-SIVsmE543-3 neutralizing antibodies were induced in all the macaques possessing the VH3.33_ET allele, but not in those without VH3.33_ET, in the chronic phase of SIVsmE543-3 infection. Next generation sequencing analysis of BCR VH genes found B404-class antibody sequences only in those with VH3.33_ET. These results indicate that anti-SIVsmE543-3 neutralizing antibody induction associated with the germline BCR IgG gene polymorphism can be triggered by infection with neutralization-resistant SIVsmE543-3. This animal model would be useful for the elucidation of the mechanism of potent antibody induction against neutralization-resistant viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Infection and Pathogenicity of Chimeric Simian-Human Immunodeficiency Viruses in Macaques: Determinants of High Virus Loads and CD4 Cell Killing.
- Author
-
Shibata, Rir, Maldarelli, Frank, Siemon, Christine, Matano, Tetsuro, Parta, Mark, Miller, Georgina, Fredrickson, Torgny, and Martin, Malcolm A.
- Abstract
Chimeric simian-human immunodeficiency viruses (SHIVs) carrying envelope glycoproteins derived from a T cell-macrophage dual-tropic primary isolate (human immunodeficiency virus type 1 [HIV-1] strain DH12) were constructed. When inoculated into macaque monkeys, SHIVMD14 carrying simian immunodeficiency virus-derived nef established significantly higher virus loads than did SHIVMD1, which contains the HIV-1 nef gene. Three patterns of CD4 cell depletion were observed in infected monkeys: exponential and irreversible loss to undetectable levels within 10 weeks of infection; marked reduction during acute infection followed by partial recovery and stabilization (lasting from 10 weeks to > 1 year), with a later decline to undetectable levels in some animals; and a transient loss during acute infection. The induced immunodeficiency was accompanied by CD4 cell counts of < 50 cells/µL and was associated with Pneumocystis carinii pneumonia, cytomegalovirus meningoencephalitis, lymphoid depletion, and thymica trophy. [ABSTRACT FROM PUBLISHER]
- Published
- 1997
40. Adaptation of skeletal muscle in limb lengthening: A light diffraction study on the sarcomere length In situ.
- Author
-
Matano, Tetsuro, Tamai, Kazuya, and Kurokawa, Takahide
- Published
- 1994
- Full Text
- View/download PDF
41. No significant enhancement of protection by Tat-expressing Sendai viral vector-booster in a macaque AIDS model.
- Author
-
Matano, Tetsuro, Kano, Munehide, Takeda, Akiko, Nakamura, Hiromi, Nomura, Nobuhiko, Furuta, Yousuke, Shioda, Tatsuo, and Nagai, Yoshiyuki
- Published
- 2003
- Full Text
- View/download PDF
42. Association of lymph-node antigens with lower Gag-specific central-memory and higher Env-specific effector-memory CD8+ T-cell frequencies in a macaque AIDS model.
- Author
-
Ishii, Hiroshi, Matsuoka, Saori, Nomura, Takushi, Nakamura, Midori, Shiino, Teiichiro, Sato, Yuko, Iwata-Yoshikawa, Naoko, Hasegawa, Hideki, Mizuta, Kazuta, Sakawaki, Hiromi, Miura, Tomoyuki, Koyanagi, Yoshio, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Published
- 2016
- Full Text
- View/download PDF
43. Highly-Sensitive Allele-Specific PCR Testing Identifies a Greater Prevalence of Transmitted HIV Drug Resistance in Japan.
- Author
-
Nishizawa, Masako, Hattori, Junko, Shiino, Teiichiro, Matano, Tetsuro, Heneine, Walid, Johnson, Jeffrey A., and Sugiura, Wataru
- Subjects
DISEASE prevalence ,GENE frequency ,DRUG resistance in microorganisms ,HIV infections ,INFECTIOUS disease transmission ,REVERSE transcriptase polymerase chain reaction ,GENETIC mutation - Abstract
Background:The transmission of drug-resistant HIV in newly identified infected populations has become an underlying epidemic which can be better assessed with sensitive resistance testing. Since minority drug resistant variants cannot be detected by bulk sequencing, methods with improved sensitivity are required. Thus, the goal of this study was to evaluate if transmitted drug resistance mutations at minority levels in Japanese patients could be identified using highly sensitive allele-specific PCR (AS-PCR). Materials and Methods:Samples were taken from newly diagnosed HIV/AIDS cases at the National Nagoya Hospital from January 2008 to December 2009. All samples were bulk sequenced for HIV protease and reverse transcriptase. To detect minority populations with drug resistance, we used AS-PCR with mutation-specific primers designed for seven reverse transcriptase inhibitor resistance mutations, M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y, and for three protease inhibitor resistance mutations, M46I/L and L90M. Results:We studied 149 newly identified HIV cases. Bulk sequencing detected 8 cases with NRTI resistance mutations (one with A62V, one D67E, one T215D, one T215E, two with T215L and two T215S) and 15 with PI resistance mutations (one with N88D and 14 with M46I). Results obtained by AS-PCR and bulk sequencing demonstrated good concordance but the AS-PCR enabled the detection of seven additional drug-resistant cases (one M41L, two with K65R, two with K70R, and one M184V) in the RT region. Additionally, AS-PCR assays identified 15 additional cases with M46I, five with M46L and four cases with L90M in the protease region. Conclusions:Using AS-PCR substantially increased the detection of transmitted drug resistance in this population from 15.4% to 26.8%, further supporting the benefit of sensitive testing among drug-naïve populations. Since the clinical impact of minority drug-resistant populations is not fully comprehended for all mutations, follow-up studies are needed to understand their significance for treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
44. Limited Impact of Passive Non-Neutralizing Antibody Immunization in Acute SIV Infection on Viremia Control in Rhesus Macaques.
- Author
-
Nakane, Taku, Nomura, Takushi, Shi, Shoi, Nakamura, Midori, Naruse, Taeko K., Kimura, Akinori, Matano, Tetsuro, and Yamamoto, Hiroyuki
- Subjects
NEUTRALIZATION (Chemistry) ,IMMUNIZATION ,VIREMIA ,RHESUS monkeys ,AIDS vaccines ,IN vitro studies ,DRUG administration ,VIRAL disease prevention - Abstract
Background:Antiviral antibodies, especially those with neutralizing activity against the incoming strain, are potentially important immunological effectors to control human immunodeficiency virus (HIV) infection. While neutralizing activity appears to be central in sterile protection against HIV infection, the entity of inhibitory mechanisms via HIV and simian immunodeficiency virus (SIV)-specific antibodies remains elusive. The recent HIV vaccine trial RV144 and studies in nonhuman primate models have indicated controversial protective efficacy of HIV/SIV-specific non-neutralizing binding antibodies (non-NAbs). While reports on HIV-specific non-NAbs have demonstrated virus inhibitory activity in vitro, whether non-NAbs could also alter the pathogenic course of established SIV replication in vivo, likewise via neutralizing antibody (NAb) administration, has been unclear. Here, we performed post-infection passive immunization of SIV-infected rhesus macaques with polyclonal SIV-specific, antibody-dependent cell-mediated viral inhibition (ADCVI)-competent non-NAbs. Methods and Findings:Ten lots of polyclonal immunoglobulin G (IgG) were prepared from plasma of ten chronically SIV
mac239 -infected, NAb-negative rhesus macaques, respectively. Their binding capacity to whole SIVmac239 virions showed a propensity similar to ADCVI activity. A cocktail of three non-NAb lots showing high virion-binding capacity and ADCVI activity was administered to rhesus macaques at day 7 post-SIVmac239 challenge. This resulted in an infection course comparable with control animals, with no significant difference in set point plasma viral loads or immune parameters. Conclusions:Despite virus-specific suppressive activity of the non-NAbs having been observed in vitro, their passive immunization post-infection did not result in SIV control in vivo. Virion binding and ADCVI activity with lack of virus neutralizing activity were indicated to be insufficient for antibody-triggered non-sterile SIV control. More diverse effector functions or sophisticated localization may be required for non-NAbs to impact HIV/SIV replication in vivo. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
45. E113 SIV control by vaccine-based Gag/Vif-specific CTL induction.
- Author
-
Matano, Tetsuro
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.